6597 POSTER A Phase II Study of Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma – a Multicenter Study of the Mayo Phase 2 Consortium (P2C) and the Cancer Therapeutics Research Group (CTRG)
Year: 2011
Type: article
Source: European Journal of Cancer
Authors: W. Yeo, H.C. Chung, S.L. Chan, L.Z. Wang, R. Lim, J. Picus, M. Boyer, C. Erlichman, A.T.C. Chan, B.C. Goh
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2084304359